John Patience - May 24, 2022 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director, Chairman, 10%+ Owner
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for John Patience
Stock symbol
BDSX
Transactions as of
May 24, 2022
Transactions value $
$0
Form type
4
Date filed
5/26/2022, 04:15 PM
Previous filing
Apr 11, 2022
Next filing
Jun 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Award $0 +83.3K $0.00 83.3K May 24, 2022 Common Stock 83.3K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock and has no expiration date.
F2 These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period.
F3 The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period.